American Journal of Otolaryngology - Head and Neck Medicine and Surgery
Volume 28, Issue 2 , Pages 78-82 , March 2007

Moxifloxacin vs amoxicillin/clavulanate in the treatment of acute sinusitis

  • José R. Arrieta, MD

      Affiliations

    • Hospital General “Dr. Manuel Gea González”, Mexico City, Mexico
    • ,
  • Alejandro S. Galgano, MD

      Affiliations

    • Departmento de Otorrinolaringologia, Policlínico Bancario, Buenos Aires, Argentina
    • ,
  • Eulalia Sakano, MD

      Affiliations

    • Clínica e Hospital de Otorrinolaringologia do Instituto Penido Bunier Ltda. Sao Paulo, Brazil
    • ,
  • Ximena Fonseca, MD

      Affiliations

    • Centro de Otorrinolaringología, Universidad Católica de Chile, Santiago, Chile
    • ,
  • Carlos F. Amábile-Cuevas, DSc

      Affiliations

    • Fundación LUSARA, Mexico City, DF, Mexico
    • Corresponding Author InformationCorresponding author. Fundación Lusara, Apartado Postal 102-006, 08930, Mexico City, DF, Mexico. Tel.: +52 55 5219 5855; fax: +52 55 5219 5855.
    • ,
  • Gerardo Hernández-Oliva, MD

      Affiliations

    • Dirección Médica, Bayer de México S.A. de C.V., Mexico City, Mexico
    • ,
  • Raul Vivar, MD

      Affiliations

    • Dirección Médica, Bayer de México S.A. de C.V., Mexico City, Mexico
    • ,
  • Gerardo González, MD

      Affiliations

    • Dirección Médica, Bayer de México S.A. de C.V., Mexico City, Mexico
    • ,
  • Arturo Torres, MD

      Affiliations

    • Dirección Médica, Bayer de México S.A. de C.V., Mexico City, Mexico
    • ,
  • the Moxifloxacin in Acute Sinusitis Study (MASS) Latin American Study Group

      Affiliations

    • The MASS Latin American Study Group. Mexico: G Hernández-Valencia, J Mañé-Ramírez, B Robles-Mariscal, E Obispo, L Hernández-Portilla, JL Vargas-Jiménez, JJ Viveros-Romero, J González-Anguiano, R Espinosa-Ulloa, J Cruz-Ponce, J Treviño-Garza, F Velásquez-Vargas, C Pane-Pianese, R Magallón, JJ Ceja, J Olguín, MR Rivera, J Pérez, Y Hernández, A Hernández. Argentina: C Ranieri, G Martínez-Goya, H Murga, H Murga Jr, G Kaminszczik, P Ontivero, C Borzi, E Goebel. Brazil: C Cidade Gomes, R Guimarães Pereira, A Miniti, L Ubirajara Sennes, R Ferreira Bento, P Santoro, L Weckx, M Scarpin Teixeira, M Mocellin, W Anselmo, S Pancotti, MSC Christo, SAC Salas. Chile: J Abiuso, F Galleguillos, P Sepúlveda, S Sanhueza, C Silva, P Matamala, A Samith, R Flaskamp.

Received 3 March 2006

References 

  1. Gwaltney JM. Acute community-acquired sinusitis. Clin Infect Dis. 1996;23:1209–1223
  2. Sinus and Allergy Health Partnership . Antimicrobial treatment guidelines for acute bacterial rhinosinusitis. Otolaryngol Head Neck Surg. 2000;123:5–31
  3. Blondeau JM. A review of the comparative in vitro activities of 12 antimicrobial agents, with a focus on five new “respiratory quinolones”. J Antimicrob Chemother. 1999;43(Suppl B):1–11
  4. Scheld WM. Maintaining fluoroquinolone class efficacy: review of influencing factors. Emerg Infect Dis. 2003;9:1–9
  5. Siegert R, Gehanno P, Nikolaidis P, et al. A comparison of the safety and efficacy of moxifloxacin (BAY 12-8039) and cefuroxime axetil in the treatment of acute bacterial sinusitis in adults. The Sinusitis Study Group. Respir Med. 2000;94:337–344
  6. Burke T, Villanueva C, Mariano H, et al. Comparison of moxifloxacin and cefuroxime axetil in the treatment of acute maxillary sinusitis. Sinusitis Infection Study Group.. Clin Ther. 1999;21:1664–1677
  7. Baz MN, Jannetti W, Villanueva C, et al. The efficacy and tolerability of moxifloxacin compared to trovafloxacin in the treatment of acute sinusitis. Todays Ther Trends. 1999;17:303–319
  8. Klossek JM, Arvis P. Moxifloxacin versus trovafloxacin in the treatment of acute bacterial maxillary sinusitis: a multinational, double-blind, randomized study. In: 11th European Congress of Clinical Microbiology and Infectious Diseases, Istanbul, Turkey. 2001;
  9. Rakkar S, Roberts K, Towe BF, et al. Moxifloxacin versus amoxicillin clavulanate in the treatment of acute maxillary sinusitis: a primary care experience. Int J Clin Pract. 2001;55:309–315
  10. Calva JJ, Niebla-Pérez A, Rodríguez-Lemoine V, et al. Antibiotic usage and antibiotic resistance in Latin America. In:  Amábile-Cuevas CF editors. Antibiotic resistance: from molecular basics to therapeutic options. Austin, TX: RG Landes/Chapman & Hall; 1996;p. 73–97
  11. Hickner JM, Bartlett JG, Besser RE, et al. Principles of appropriate antibiotic use for acute rhinosinusitis in adults: background. Ann Intern Med. 2001;134:498–505
  12. Sader HS, Gales AC, Granacher TD, et al. Prevalence of antimicrobial resistance among respiratory tract isolates in Latin America: results from SENTRY antimicrobial surveillance program (1997-98). Braz J Infect Dis. 2000;4:245–254
  13. Critchley IA, Thornsberry C, Piazza G, et al. Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis collected from five centers in Brazil, 1997-98. Clin Microbiol Infect. 2000;6:178–184
  14. Gehanno P, Darantière S, Dubreuil C, et al. A prospective multicenter study of moxifloxacin concentrations in the sinus mucosa tissue of patients undergoing elective surgery in the sinus. J Antimicrob Chemother. 2002;49:821–826
  15. Dinis PB, Monteiro MC, Martins ML, et al. Sinus tissue concentration of moxifloxacin after a single oral dose. Ann Otol Rhinol Laryngol. 2004;113:142–146

☆ This study was supported by Bayer AG (Pharma Research Center and Medical Research Department), Wuppertal, Germany, and Bayer de México, SA de CV, Mexico City, Mexico.

PII: S0196-0709(06)00124-4

doi: 10.1016/j.amjoto.2006.06.016

American Journal of Otolaryngology - Head and Neck Medicine and Surgery
Volume 28, Issue 2 , Pages 78-82 , March 2007

Article Tools